Home » Health News » Targeted therapy achieves responses across multiple cancer types with FGFR alterations

Health News

Targeted therapy achieves responses across multiple cancer types with FGFR alterations

Targeted therapy achieves responses across multiple cancer types with FGFR alterations

Erdafitinib demonstrates tumor-agnostic benefits across 16 cancer types

Adding immunotherapy to erdafitinib elevates response rates in advanced urinary tract cancers

Erdafitinib significantly improves patient outcomes over chemotherapy in FGFR-altered urinary tract cancers

Source: Read Full Article

Related posts:
  1. Turns out science says you can change your personality. Here’s how
  2. Covid update: Could your hair loss signal COVID-19? What the research says
  3. Second British baby gets world's most expensive drug on the NHS
  4. 200 kids sent to NHS in the past year for gaming addiction